Biotech Blog

Coming soon, a book by frequent BiotechBlog contributor, John Avellanet. In this new book — Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine — John teaches you how to take advantage of evolving FDA compliance requirements and cutting-edge new product development techniques to bring your new [...]

DC Biotech is an informal networking group in the DC area. A discussion forum is hosted on LinkedIn, and regular happy hours are held in the DC area.

I recently gave a talk on educating the next generation of biotechnology managers and founders at a biotechnology education workshop. My sense is that the traditional education paths are not ideal ways to prepare individuals to manage or start biotechnology companies, and I describe cases from Best Practices in Biotechnology Education and courses I have [...]

Drug Patent Expirations in March 2010
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

AZASITE
Inspire
azithromycin
5,192,535
Mar 9, 2010

SOLAGE
Stiefel Labs Inc
mequinol; tretinoin
5,470,567
Mar 19, 2010

PYLERA
Axcan Scandipharm
bismuth subcitrate potassium; metronidazole; tetracycline
5,476,669
Mar 23, 2010

KADIAN
Actavis Elizabeth
morphine sulfate
5,378,474
Mar 23, 2010

PYLERA
Axcan Scandipharm
bismuth subcitrate potassium; metronidazole; tetracycline
5,196,205
Mar 23, 2010

EMBEDA
Alpharma King
morphine sulfate; naltrexone hydrochloride
5,378,474
Mar 23, [...]

The judging is underway for the Biotech Humanitarian Award. The pool of nominees was divided between the judges, so I’ve only seen some of them, but I’ve made my selections. One of the elements I’ve been looking for is evidence of going beyond one’s job description — how much has an individual done to drive [...]

I will be giving a talk on Educating the Next Generation of Biotechnology Founders and Managers at Pittcon in Orlando on March 1st.
The talk will be based on my observations in writing  Building Biotechnology and editing Best Practices in Biotechnology Education, in addition to the teaching I’ve done on the topic. I’ll be posting my [...]

Drug Patent Expirations in February 2010
*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ZAGAM
Mylan
sparfloxacin
4,795,751
Feb 4, 2010

TEVETEN
Abbott
eprosartan mesylate
5,185,351
Feb 9, 2010

MYOVIEW
Ge Healthcare
technetium tc-99m tetrofosmin kit
5,045,302
Feb 9, 2010

TEVETEN HCT
Abbott
eprosartan mesylate; hydrochlorothiazide
5,185,351
Feb 9, 2010

HYZAAR
Merck
hydrochlorothiazide; losartan potassium
5,138,069*PED
Feb 11, 2010

COZAAR
Merck
losartan potassium
5,138,069*PED
Feb 11, 2010

EXUBERA
Pfizer
insulin recombinant human
RE37872
Feb 12, 2010

EXUBERA
Pfizer
insulin recombinant human
RE38385
Feb 12, 2010

MEPRON
Glaxosmithkline
atovaquone
4,981,874*PED
Feb 15, 2010

NITRO-DUR
Key Pharms
nitroglycerin
5,186,938
Feb 16, 2010

SANDIMMUNE
Novartis
cyclosporine
7,511,014
Feb 16, 2010

ALDARA
Graceway
imiquimod
4,689,338*PED
Feb 25, [...]

Are you a leader in the biotechnology industry? Do you have specialized expertise and a strong network?
I am looking for a few new members to join the Journal of Commercial Biotechnology’s editorial board. Board member responsibilities include authoring papers, soliciting papers, and reviewing papers. Please check out the journal’s homepage and sample papers for a [...]

I’m giving a talk at Pittcon on biotechnology training this spring. As many readers know, I have been very active in biotechnology education through my books and the classes I teach. So, I’ve got a strong sense of the supply-side of biotechnology education and training, and the academic side of biotechnology education, but would like [...]

Moira Gunn’s Tech Nation interview of Jeremy Abbate and I on the Scientific American worldView project is now available at IT Conversations. For more details, you can also see our video interview and the worldView website.